Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 03-1992 | 12-1991 | |
| Sales | 443,722 | 441,947 | 0 | 418,000 | 0 |
| Gross Profit | 443,722 | 441,947 | N/A | 418,000 | N/A |
| Operating Income | 443,722 | 441,947 | N/A | 418,000 | N/A |
| Pre-tax Income | 443,722 | 441,947 | 0 | 418,000 | 0 |
| Net Income Continuous | 43,359 | 48,731 | 63,800 | 50,800 | N/A |
| Net Income Discontinuous | 0 | 0 | 0 | -1,998,000 | N/A |
| Net Income | $43,359 | $48,731 | $63,800 | $50,800 | $N/A |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | N/A |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.27 | N/A |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | N/A |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.27 | N/A |
| EBITDA(a) | $443,722 | $441,947 | $N/A | $418,000 | $N/A |